Application of Cyclodextrin for Cancer Immunotherapy
Tumor immunotherapy, compared with other treatment strategies, has the notable advantage of a long-term therapeutic effect for preventing metastasis and
Tag: prodrug
Glutathione-depleted cyclodextrin pseudo-polyrotaxane nanoparticles for anti-inflammatory oxaliplatin (IV) prodrug delivery and enhanced colorectal cancer therapy
Oxaliplatin (Oxa) is the first-line chemotherapeutic drug for the treatment of colorectal cancer (CRC). However, long-term Oxa chemotherapy can induce
Covalent cyclodextrin framework for targeted therapy of inflammatory bowel disease
The incidence and prevalence of inflammatory bowel disease (IBD) are steadily rising worldwide, where the pathogenesis and progression are intrinsically
Cyclodextrin as a magic switch in covalent and non-covalent anticancer drug release systems
This article reviews the controlled release of current anticancer drugs based on cyclodextrins as a “flexible switch”, and discusses the